New research demonstrates the importance of genetic testing for many cancers not currently covered by clinical guidelines

Study findings to be presented at the 2024 ASCO Annual Meeting reveal hereditary risk for stomach and lung cancer, among others, underscoring the need for more widespread genetic testing SAN FRANCISCO, May 23, 2024 /PRNewswire/ — the invitation (OTC:NVTAQ), a leading medical genetics company, today announced eight studies to be presented at the 2024 American … Read more